Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT00374803
Eligibility Criteria:
Inclusion Criteria:
* Males and females between 18 and 75 years of age.
* Patients who are primary or repeat cadaveric, living unrelated or non-HLA identical living related donor renal transplant recipients.
Exclusion Criteria:
* Patient previously received or is receiving an organ transplant other than kidney.
* Primary or re-transplant from human leukocyte antigen (HLA)-identical living donor.
* Recipient or donor is known to be seropositive for hepatitis C virus (HCV), hepatitis B virus (HBV), or human immunodeficiency virus (HIV).
* Uncontrolled concomitant infection or other unstable medical condition.
* Patients that received an investigational drug in the 30 days prior to transplant.
* Known hypersensitivity to tacrolimus, mycophenolate mofetil (MMF), enteric-coated mycophenolic acid, rabbit anti-thymocyte globulin, or corticosteroids.
* Receiving chronic steroid therapy at the time of transplant.
* History of malignancy in last 5 years.
* Pregnant or lactating.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00374803
Study Brief:
Protocol Section:
NCT00374803